The impact of knowledge of HPV positivity on cytology triage in primary high-risk HPV screening

被引:8
|
作者
Aitken, Clare A. [1 ]
Holtzer-Goor, Kim M. [2 ]
Uyterlinde, Anne [3 ]
van den Brule, Adriaan J. C. [4 ]
van der Linden, Hans C. [4 ]
Huijsmans, Cornelis J. [4 ]
de Kok, Inge M. C. M. [1 ]
van Kemenade, Folkert J. [5 ]
机构
[1] Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands
[2] Dutch Natl Inst Publ Hlth & Environm, Ctr Populat Screening, Bilthoven, Netherlands
[3] Facilitaire Samenwerking Bevolkingsonderzoeken, Utrecht, Netherlands
[4] Jeroen Bosch Hosp, Pathol DNA, Shertogenbosch, Netherlands
[5] Erasmus MC Univ Med Ctr, Dept Pathol, Rotterdam, Netherlands
关键词
hrHPV screening; cervical cytology; cervical cancer screening;
D O I
10.1177/0969141319864991
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective Several studies have shown that there is an upward shift in the classification of cervical cytology when high-risk human papillomavirus (hrHPV) status is known to be positive. The Netherlands implemented primary hrHPV screening with reflex cytology as the primary screening test in 2017. Prior to implementation of the new programme, we investigated whether knowledge of hrHPV status influences cytology rating. Methods Using a set of 200 cytology slides that had been previously tested, two pairs of cytotechnicians rated 100 slides per pair twice: first without knowledge of hrHPV status and then, after a wash-out period of two months, with knowledge of hrHPV status. Results We found that hrHPV positive slides were more likely to be rated up over the referral threshold (i.e. from negative for intraepithelial lesion or malignancy to atypical squamous cells of undetermined significance+) than hrHPV negative slides at the second review when hrHPV status was known (relative risk = 3.2; 95% confidence interval: 1.3-7.9). Conclusions If the same upward shift in ratings were to be observed in the national programme, it may have implications for referrals of women with low-grade lesions.
引用
收藏
页码:221 / 224
页数:4
相关论文
共 50 条
  • [41] Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening
    Wei, Baojun
    Mei, Ping
    Huang, Shengkai
    Yu, Xueting
    Zhi, Tong
    Wang, Guojing
    Xu, Xiaotian
    Xiao, Lin
    Dong, Xin
    Cui, Wei
    VIROLOGY JOURNAL, 2020, 17 (01)
  • [42] Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening
    Baojun Wei
    Ping Mei
    Shengkai Huang
    Xueting Yu
    Tong Zhi
    Guojing Wang
    Xiaotian Xu
    Lin Xiao
    Xin Dong
    Wei Cui
    Virology Journal, 17
  • [43] Cost-Effectiveness of Primary HPV Screening Strategies and Triage With Cytology or Dual Stain for Cervical Cancer
    Tantitamit, Tanitra
    Khemapech, Nipon
    Havanond, Piyalamporn
    Termrungruanglert, Wichai
    CANCER CONTROL, 2020, 27 (01)
  • [44] Retrospective study of the influence of HPV persistence on outcomes among women with high-risk HPV infections and negative cytology
    Bogani, Giorgio
    Taverna, Francesca
    Lombardo, Claudia
    Borghi, Chiara
    Martinelli, Fabio
    Signorelli, Mauro
    Maggiore, Umberto Leone Roberti
    Chiappa, Valentina
    Scaffa, Cono
    Ditto, Antonino
    Lorusso, Domenica
    Raspagliesi, Francesco
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2017, 138 (01) : 62 - 68
  • [45] Validation of a DNA Methylation Panel for the Triage of HPV Positive Women in a HPV Primary Screening Population
    Reynods, Stephen
    White, Christine M.
    Naik, Padmaja
    O'Brien, Roisin
    Powles, Caroline
    Keegan, Helen
    O'Crowley, Jacqui Barry
    Tewari, Prerna
    O'Toole, Sharon
    Normand, Charles
    Flannelly, Grainne
    Martin, Cara
    O'Leary, John
    MODERN PATHOLOGY, 2018, 31 : 447 - 447
  • [46] Validation of a DNA Methylation Panel for the Triage of HPV Positive Women in a HPV Primary Screening Population
    Reynods, Stephen
    White, Christine M.
    Naik, Padmaja
    O'Brien, Roisin
    Powles, Caroline
    Keegan, Helen
    O'Crowley, Jacqui Barry
    Tewari, Prerna
    O'Toole, Sharon
    Normand, Charles
    Flannelly, Grainne
    Martin, Cara
    O'Leary, John
    LABORATORY INVESTIGATION, 2018, 98 : 447 - 447
  • [47] High-Risk HPV Status in Primary and Metastatic Carcinomas of the Lung
    Bishop, J. A.
    Illei, P. B.
    Gabrielson, E.
    Westra, W. H.
    MODERN PATHOLOGY, 2011, 24 : 405A - 405A
  • [48] Evidence based appropriate triage strategies for implementing high risk HPV as primary technology in cervical cancer screening
    Pimple, Sharmila A.
    Mishra, Gauravi A.
    Deodhar, Kedar K.
    MINERVA GINECOLOGICA, 2020, 72 (02): : 96 - 105
  • [49] A cohort study of cervical screening using partial HPV typing and cytology triage
    Schiffman, Mark
    Hyun, Noorie
    Raine-Bennett, Tina R.
    Katki, Hormuzd
    Fetterman, Barbara
    Gage, Julia C.
    Cheung, Li C.
    Befano, Brian
    Poitras, Nancy
    Lorey, Thomas
    Castle, Philip E.
    Wentzensen, Nicolas
    INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (11) : 2606 - 2615
  • [50] Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
    Arbyn, M.
    Snijders, P. J. F.
    Meijer, C. J. L. M.
    Berkhof, J.
    Cuschieri, K.
    Kocjan, B. J.
    Poljak, M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (09) : 817 - 826